Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Lung cancer in sheep offers clues to detection in humans
The virus infects the lungs of sheep and triggers the growth of cancerous cells
Advances in understanding may lead to new diagnostic tests

A new study, published recently in the Journal of Virology, has identified genetic changes occurring during the growth of lung cancer in sheep that improve understanding of how the disease develops. This could help lead to earlier diagnosis of the disease in sheep and in humans.

Ovine pulmonary adenocarcinoma (OPA) is an infectious and deadly lung disease of sheep, caused by the Jaagsiekte sheep retrovirus (JSRV). The virus infects the lung and triggers the growth of cancerous cells. Affected cells then produce more of the virus; which can infect new areas of the lung or spread to other sheep. While JSRV affects sheep and goats, it cannot be passed on to humans or other animals.

In affected flocks, OPA can result in the death of one to 20 per cent of the sheep in a year and poses a significant economic problem for farmers as a result. However, the reason why the sheep respond so badly to the virus is currently poorly understood.

The study, led by researchers from the Moredun Research Institute and the University of Edinburgh, looked at how lung cells change when infected with JSRV. It was found that cells related to the immune system and the formation of cancer had altered gene expression, which affects the production of proteins important for cell function.

“Understanding the genes that are switched on or off during JSRV infection provides important clues as to how the virus initiates cancer and may lead to novel routes for combating the disease,” said Dr David Griffiths of the Institute.

Investigating OPA also represents a valuable tool for studying some forms of human lung cancer, owing to similarities in how the cancer cells are activated in the sheep and human diseases.  By comparing their results on OPA to previously published data on human lung cancer, the research team found a large degree of overlap in the genes that were ‘faulty’.

Lung cancer is difficult to diagnose in its early stages in both sheep and humans and the discovery of common markers could lead to improved early detection of cancer in both sheep and humans.

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.